Trial Profile
Drug Use-results Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Apr 2020
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Astellas Pharma
- 07 Apr 2020 Status changed from active, no longer recruiting to completed.
- 08 Jan 2020 Status changed from recruiting to active, no longer recruiting.
- 08 Feb 2018 Status changed from not yet recruiting to recruiting.